Modifications in transcutaneous oxygen pressure (TcPO2), induced by the administration of 3 mg/kg/day buflomedil chlorhydrate for seven days were evaluated in 12 subjects suffering from peripheral vascular disease (PVD). After the treatment a significant increase in TcPO 2 basal values was observed in Stage III and Stage IV PVD patients (+32.2%) while a significant reduction of 12 % in the half-recovery time to basal val ues after an induced ischemia was re corded in Stage II PVD patients by the seventh day. Buflomedil did not, however, cause any significant varia tions in the ankle/arm pressure ratio or in the plethysmographic peak flow.
Get full access to this article
View all access options for this article.
References
1.
Dormandy JA, Ernest E.: Effects of buflomedil on erythrocyte deformability. Angiology32:714-716, 1981.
2.
Wurzinger JL, Holger Schmid-Schonbein: Effects of buflomedil on platelet aggregation. Microcirculation and ischemic diseases. Proceedings of Congress , Rio de Janeiro, 1981.
3.
Trubestein G. , Balzer K., Bisler H., et al: Buflomedil in arterial occlusive disease: Results of a controlled multi-center study. Angiology35:500-504, 1984.
4.
Rosas G., Cerdeyra C., Lucas MA, et al: Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication. Angiology291-297, 1981.
5.
Mannarino E. , Maragoni G., Pasqualini L., et al: Transcutaneous oxygen tension behavior in the different stages of peripheral vascular disease and its correlation with ankle/arm pressure ratio and calf blood flow. Angiology38:463-468, 1987.
6.
Byrne P., Provan JL, Ameli FM, et al: The use of transcutaneous oxygen tension measurements in the diagnosis of peripheral vascular insufficiency. Ann Surg200:159-165, 1984.
7.
Bongard O., Krahenbuhl B.: Pedal blood flow and transcutaneous PO2 in normal subjects and in patients suffering from severe arterial occlusive disease. Clin Physiol4:393-401, 1984.
8.
Kram HB, White RA, Tabrysky J., et al: Transcutaneous oxygen recovery and toe pulse reappearance time in the assessment of peripheral vascular disease. Circulation72:1022-1027, 1985.
